Models of care toolkit

Optimizing scope of practice

There are opportunities within models of care, to engage all members of the care team in care delivery, symptom management, patient education and decision-making. Models that limit routine cancer care to specialists can require patients to travel long distances to receive care and can increase pressure on cancer systems already under strain. In rural and remote communities, models of care that optimize scopes of practice for non-specialists are already used.

Cancer care is often supported by family physicians or other primary care teams with nurses, nurse practitioners and general practitioners in oncology (GPO). Empowering all health care providers to work to their full scope of practice may require a formal or informal change to professional scopes of practice as legislation, certification or health care centre allows.

Enhancing the role of pharmacists in cancer care

On the left-hand side of the image is a male pharmacist holding a bag of prescriptions. On the right-hand side of the image is a group of nurses and doctors. There is a plus sign in the middle of the images signaling how they can come together as one team.Pharmacists play a critical role on cancer care teams. This role continues to evolve with advances in dispensing technology, new pharmacist training and credentialling opportunities, and incremental expansion of prescribing authority.

There are significant benefits to models of care that include pharmacists:

  • Supporting physicians to balance their workload
  • Providing pain management
  • Reducing adverse drug reactions and chemotherapy errors
  • Advancing community-based cancer screening and referrals
  • Reducing unplanned health care utilization

A rapid review identified two broad ways in which pharmacists are integrated into the cancer system:

  • In outpatient and community settings, pharmacists provide medication dose optimization, adjustments for supportive medications, interventions for medication-related problems, and among other services.
  • In multidisciplinary teams, pharmacists enhance patient knowledge about medication, support team members to develop and adjust medication regimens, ensure medication safety, and assist in financial review of patient medications.

Addressing demands on nurses and other health care providers

icon three nurses

Nurses and nurse practitioners are critical to patient care in the cancer system. In addition to hands on care delivery, they provide patient navigation, care planning, primary care and support to patients between appointments.
With the expanding role of nurses and nurse practitioners across models of care, there is risk of overburdening the nursing health workforce, leading to work-related stress and exhaustion, and potentially causing mental health disorder symptoms.

Innovative approaches to address these challenges are needed that effectively use existing resources, while ensuring safe, supportive and ethical work environments, including mental health and wellness supports.

Support resources are available through leading Canadian organizations including: Health Care Excellence Canada and the Centre for Addiction and Mental Health

  1. Williamson S, Beaver K, Gardner A, Martin-Hirsch P. Telephone follow-up after treatment for endometrial cancer: A qualitative study of patients’ and clinical nurse specialists’ experiences in the ENDCAT trial. Eur J Oncol Nurs. 2018;34:61-67.
  2. Beaver K, Williamson S, Sutton CJ, Gardner A, Martin-Hirsch P. Endometrial cancer patients’ preferences for follow-up after treatment: A cross-sectional survey. Eur J Oncol Nurs. 2020;45(101722):101722..
  3. Beaver K, Williamson S, Sutton C, et al. Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial. BJOG. 2017;124(1):150-160.
  4. Cohen PA, Webb PM, King M, et al. Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer. Int J Gynecol Cancer. Published online 2021:ijgc-2021-002999.
  5. Schenker Y, Althouse AD, Rosenzweig M, et al. Effect of an oncology nurse-led primary palliative care intervention on patients with advanced cancer: The CONNECT cluster randomized clinical trial: The CONNECT cluster randomized clinical trial. JAMA Intern Med. 2021;181(11):1451-1460.
  6. Komatsu H, Yagasaki K, Yamaguchi T, et al. Effects of a nurse-led medication self-management programme in women with oral treatments for metastatic breast cancer: A mixed-method randomised controlled trial. Eur J Oncol Nurs. 2020;47(101780):101780.
  7. Nelson S, Turnbull J, Bainbridge L, et al. Optimizing Scopes of Practice: New Models for a New Health Care System.; 2014. Accessed November 22, 2021. https://www.cahs-acss.ca/wp-content/uploads/2014/08/Optimizing-Scopes-of-Practice_REPORT-English.pdf